Healthcare & Life Sciences
Retrosense Therapeutics
United States
acquiredacquired
acquired
Stage
About
Retrosense Therapeutics was a biotechnology company focused on developing therapeutic approaches for vision restoration and was acquired by Allergan in 2016.
Explore Retrosense Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.